What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’

• UnitedHealth raised 2026 adjusted EPS guidance to $19.50-$20, above the $18.48 consensus.
• Medicare Advantage drove the beat, with margins expected above 3% despite a projected 1.1 million-member decline.
• UNH called the earnings “exceptional” and “durable,” while AI initiatives boosted patient-facing hours and cut clinician burnout.

Shares of UnitedHealth Group, Inc. (UNH) rose to their highest level in more than a year on Thursday after the healthcare giant raised its 2026 earnings outlook, posted a major profit beat and doubled its stock-buyback plan.

UNH stock rose 1% on Thursday to end the session at $423.38, with shares rising another 1% in extended trading. 

UNH Q2 Review

UnitedHealth reported second-quarter adjusted earnings of $6.38 per share, well above the $4.92 consensus estimate and up from $4.08 a year earlier. Revenue came in at $112.03 billion, topping Wall Street’s $110.86 billion estimate and remaining broadly flat year-over-year. The medical care ratio improved to 86.7% from 89.4%, helped by $860 million of favorable prior-period medical development. 

UnitedHealth also raised its 2026 adjusted EPS outlook to $19.50-$20, well above the $18.48 consensus and its previous forecast of more than $18.25. The company increased UnitedHealthcare’s operating-profit outlook to at least $12 billion and lifted Optum Health’s forecast to at least $2.2 billion.

CEO Says UnitedHealth Is ‘Returning To Form’ 

CEO Stephen Hemsley said on the company’s earnings call that UnitedHealth was seeing “stronger broad-based performance disciplines taking hold” across the business. 

“We are addressing those challenges and returning to form,” he said. Hemsley also reaffirmed the company’s long-term goal of 13% to 16% annual earnings growth. “We continue to be in that mindset of that 13%-16%,” he said. “Really never believed otherwise.”

Bigger Buyback Signals Confidence 

UnitedHealth raised its 2026 share-repurchase target to at least $5 billion from $2.5 billion. It had already spent $4 billion buying back 11.4 million shares through mid-July.

CFO Wayne DeVeydt called the earnings “quite durable” and said the new outlook was “the right stepping off point” for future growth. Hemsley additionally said: “I think the quality of earnings is exceptional.”

Medicare Advantage Drives UNH Beat

Stronger Medicare Advantage results drove the quarter, with medical costs coming in below UnitedHealth’s assumptions. “Medicare delivered a strong second quarter,” UnitedHealthcare CEO Tim Noel said. The company still expects Medicare Advantage enrollment to fall by about 1.1 million this year, but margins are forecast above 3%.

Commercial plans remain under pressure, with medical-cost trends running modestly above 11%. “Commercial costs are stubbornly high,” Noel said, adding that the pressure was being felt “across the sector.”

UnitedHealth is leaning heavily on AI to cut administrative work and improve productivity. “We are really thinking of it in terms of reimagining our entire enterprise,” Hemsley said, calling AI “the operating infrastructure of the future.” 

Optum said AI tools helped add nearly 200,000 patient-facing hours, cut clinician cognitive burnout by 90% and delivered a 96% first-pass approval rate for digital prior authorizations. “We’re making solid early progress,” Hemsley said. “We have much more work ahead.”

How Do Retail Traders Feel About UNH?

On Stocktwits, retail sentiment for UNH jumped to ‘extremely bullish’ from ‘bullish’ levels a day ago amid nearly a 500% surge in 24-hour message volumes.

One user said, “$UNH what a disappointing day after blowout earnings!! Expected this to work to $500!”

Another user said, “$UNH Really strange movement based off earnings.. My guess is a lot of people were waiting to get out and this was their chance. Should move up from here”

UNH stock has risen 49% over the past year.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: RKLB, SPCX, ASTS Head For Over 30% July Losses — Goldman Says Space Stocks Are 5x More Volatile Than S&P 500